PAYER POLICY CHANGES

G2069 Insurance Policy Changes

HCPCS G2069 is officially defined as "Medication assisted treatment, buprenorphine (injectable) administered on a monthly basis; bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)." HCPCS G2069 is referenced in 7 tracked payer policy changes from Sentara Health Plans, Ambetter, and 3 other payers. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS G2069 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Watch G2069

Get one email when a payer policy names G2069, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

See every payer rule for G2069

Prior authorization lists, coverage criteria, NCCI edits and Medicare coverage articles for G2069 in one place.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.